REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB

被引：0
|
作者：
Raluy-Callado, Mireia
Carroll, Robert
Curtis, Rebecca
Khalid, Javaria Mona
Patel, Haridarshan
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 01期
关键词：
D O I：
10.1053/j.gastro.2017.11.249
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P190
引用
收藏
页码：S105 / S106
页数：2
相关论文
共 50 条
  • [1] REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Raluy-Callado, Mireia
    Carroll, Robert
    Curtis, Rebecca
    Khalid, Javaria Mona
    Patel, Haridarshan
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S74 - S75
  • [2] Colombian real-world experience of vedolizumab use in patients with inflammatory bowel disease-EXVEDOCOL
    Parra Izquierdo, V.
    Cifuentes Amortegui, S.
    Avendano R, S.
    Ponce de Leon, E.
    Florez, C.
    Reyes Medina, G.
    Puentes M, F. E.
    Ballesteros B, M.
    Nunez, E. E.
    Hemandez, M.
    Kock, J.
    Marquez, J. R.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S181 - S182
  • [3] Real-world experience of vedolizumab use in Colombian patients with inflammatory bowel disease--EXVEDOCOL
    Parra, Viviana
    Cifuentes, Sandra
    Avendano, Sandra
    de Leon, Enrique Ponce
    Florez, Cristian
    Reyes, Gustavo
    Puentes, Fabian
    Ballesteros, Manuel
    Nunez, Edilberto
    Gomez, Federico
    Marquez, Juan Ricardo
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2024, 47 (08): : 858 - 866
  • [4] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison Borrman
    Bensen, Rachel
    Goyal, Alka
    GASTROENTEROLOGY, 2024, 166 (05) : S1210 - S1211
  • [5] Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting
    Kolehmainen, Sara
    Ylisaukko-Oja, Tero
    Jokelainen, Jari
    Koivusalo, Mirkka
    Jokiranta, T. Sakari
    Sipponen, Taina
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (08) : 906 - 913
  • [6] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison
    Bensen, Rachel
    Goyal, Alka
    GASTROENTEROLOGY, 2024, 166 (03) : S101 - S102
  • [7] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison
    Bensen, Rachel
    Goyal, Alka
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S73 - S74
  • [8] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Anjur, Kavya
    Neiman, Nicole
    Kotzen, Alison
    Pond, Stephen
    Goyal, Alka
    GASTROENTEROLOGY, 2022, 162 (07) : S826 - S826
  • [9] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE ADMINISTERED VEDOLIZUMAB FOR 6 MONTHS
    Cohen, Benjamin
    Chang, Helena L.
    Rogers, Jason
    Garg, Shashank
    Lawrence, Debra
    Fasihuddin, Farah
    Lissoos, Trevor
    Atreja, Ashish
    GASTROENTEROLOGY, 2020, 158 (06) : S659 - S659
  • [10] Real-world healthcare resource utilisation among patients with inflammatory bowel disease administered vedolizumab for 6 months
    Cohen, B.
    Chang, H.
    Rogers, J. R. Jason
    Garg, S.
    Lawrence, D.
    Fasihuddin, F.
    Lissoos, T.
    Atreja, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S058 - S059
12345